Fiorella Avant
Family Medicine · Yukon, OKNPI 1437478526
Payments from drug & device makers
Across 239 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$352
- Lilly USA, LLC$342
- Otsuka America Pharmaceutical, Inc.$263
- Novo Nordisk$251
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$249
- GSK$197
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,518100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 38 | $352 |
| Lilly USA, LLC | 33 | $342 |
| Otsuka America Pharmaceutical, Inc. | 11 | $263 |
| Novo Nordisk | 16 | $251 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $249 |
| GSK | 13 | $197 |
| Amgen | 11 | $176 |
| Boehringer Ingelheim | 11 | $173 |
| Supernus Pharmaceuticals, Inc. | 13 | $168 |
| Abbott | 8 | $159 |
| AbbVie(2 entities) | 7 | $131 |
| Dexcom, Inc. | 6 | $128 |
| Astellas Pharma US Inc | 6 | $91 |
| Merck | 6 | $87 |
| Harmony Biosciences LLC | 3 | $82 |
| Bayer | 5 | $73 |
| Teva Pharmaceuticals USA, Inc. | 5 | $63 |
| Sunovion Pharmaceuticals Inc. | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Organon | 3 | $40 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $34 |
| Johnson & Johnson | 2 | $33 |
| Eisai Inc. | 1 | $24 |
| AstraZeneca | 2 | $24 |
| Amneal Pharmaceuticals LLC | 2 | $24 |
| Insulet Corporation | 1 | $23 |
| Medtronic | 1 | $23 |
| Edwards Lifesciences | 1 | $22 |
| Novartis | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Vertex | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
How this compares
$3,530 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $16,727 |
| EliquisApixaban | 19 | $15,845 |
| OzempicSemaglutide | 11 | $12,384 |
| TrulicityDulaglutide | 12 | $11,944 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,477 |
| FarxigaDapagliflozin Propanediol | 13 | $7,092 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,207 |
| Pregabalin | 39 | $1,078 |
| Tizanidine Hcl | 35 | $1,050 |
| Trazodone Hcl | 25 | $981 |
| Levothyroxine Sodium | 71 | $786 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $717 |
| Tramadol Hcl | 35 | $626 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $510 |
| Ondansetron OdtOndansetron | 27 | $477 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Arnuity Ellipta | $197 | $18,93428 claims |
| PfizerEliquis | $352 | $15,84519 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $24 | $14,56925 claims |
| Novo NordiskOzempic | $251 | $12,38411 claims |
| Lilly USA, LLCTrulicity | $342 | $11,94412 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $24 | $78671 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Yukon
- Kyle RicknerYukon$14.7M
- Robert LockwoodYukon$8.6M
- Carl GriffinOklahoma City$28.2M
- Lisa ConneryNorman$15.6M
- Steven CoxNorman$6.9M
- Alexander FrankOklahoma City$3.1M
- Rachel AndersonNorman$2.8M
- Robert WestcottLindsay$1.6M
- Charles LunnOklahoma City$1.4M
- Jeffrey ChasteenTulsa$820K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.